New $50 billion weight loss drug could rival Ozempic

A weight loss drug going through clinical trials could be five times as profitable as other popular weight loss drugs on the market because of its strong success in managing obesity. Originally approved for diabetes management, semaglutide drugs like Ozempic and Wegovy have captured consumers'…

#ozempicandwegovy #elonmusk #elililly #mounjaro #ozempic #glp1 #tirzepatide #katiepage #anelililly